Ascendis Pharma A/S (BVMF:A1SN34)
76.05
-2.52 (-3.21%)
At close: Mar 24, 2026
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of 75.82 billion as of April 10, 2026. Its market cap has increased by 38.30% in one year.
Market Cap
75.82B
Enterprise Value
77.34B
Revenue
4.66B
Ranking
n/a
PE Ratio
n/a
Stock Price
76.05
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from 1.07B to 75.82B, an increase of 6,992.75%. That is a compound annual growth rate of 46.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 75.82B | 5.17% |
| Dec 31, 2025 | 72.09B | 41.57% |
| Dec 31, 2024 | 50.92B | 47.30% |
| Dec 29, 2023 | 34.57B | -4.17% |
| Dec 30, 2022 | 36.07B | -15.20% |
| Dec 31, 2021 | 42.54B | -9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 88.08B |
| Raia Drogasil | 38.93B |
| Hypera | 14.69B |
| Fleury | 8.67B |
| Odontoprev | 7.68B |
| Diagnósticos da América | 3.90B |
| Empreendimentos Pague Menos | 3.71B |
| Blau Farmacêutica | 2.45B |